Due to the lack of effective treatments for many chronic diseases, including Alzheimer’s disease, pancreatic cancer and brain tumors, improving the value of certain types of care can only go so far, according to editorial author David Shaywitz, MD. Instead of “optimizing these relatively poor choices,” healthcare should focus on the development of better treatments and technologies to transform the field, Dr. Shaywitz writes.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
To avoid delivering what Dr. Shaywitz terms “low-value medicine served with marvelous efficiency,” he urges healthcare stakeholders to consider the idea that quality is not just about “removing the negative, and eliminating what clearly doesn’t work in healthcare; [it] should also require us to continuously ask how we can use emerging technologies to advance the frontiers of knowledge, especially in areas where the very best evidence-based care is clearly not good enough.”
More Articles on Quality:
6 Key Statistics on Medicare Beneficiaries’ Access to Physicians
Study: Heart Failure Treatment Cost Soars While Mortality Drops
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
